Cost-Effective & Scalable Process Analytical Technologies in Biotech & Pharma
Demonstrating the Value of Efficient PAT, AI & Machine Learning in Drug & Biologics Development & Manufacturing to Ensure Product Consistency
As demand surges for GLP-1s, small molecules, and complex biologics, the industry faces increasing pressure to innovate and optimize manufacturing processes to meet the needs of Pharma 4.0. The 4th PAT & Real Time Quality Summit offers a unique opportunity to explore how Process Analytical Technology is transforming drug development and manufacturing, ensuring product consistency and reducing waste.Â
Across three days, 18+ industry leaders will share case studies, discuss the latest analytical tools, and demonstrate how digital technologies can be applied throughout the biologics and drug product lifecycle to save time and money. Attendees will dive into key topics, including regulatory updates, real-time release testing, and tech transfer challenges, while exploring the application of PAT for various drug modalities, including CGT, vaccines, peptides, and small molecules.Â
With experts from top pharma companies such as AstraZeneca, GlaxoSmithKline, and Pfizer, this summit provides an unmatched platform to discuss strategies for improving processes and accelerating the adoption of scalable, cost-effective PAT solutions.
Don't miss the chance to connect with other PAT practitioners and gain the insights needed to navigate the future of pharma manufacturing.
Full Event Guide
What's New in 2025?
Interactive Regulatory Compliance Workshop
➜ Kickstart your summit experience with the pre-conference workshop led by Farshid Mohammadparast of the US Pharmacopeia to discuss key recent regulations and guidelines that govern the use of PAT in
manufacturing of drugs and biological products
➜ Gain exclusive insights into understanding model validation workflows and addressing challenges for validating models for real time release testing (RTRT)
Putting PAT in Practice
➜ This year's summit is shifting from exploring what’s possible in PAT to implementing what works. The focus is on real-world PAT execution, validation, and the organizational roadblocks that often stand in the way of adoption.
➜ Learn about strategies for validation, scale-up, and cross-functional buy-in from leading teams at Lonza, GSK, Johnson & Johnson and many more.
New Companies on the Agenda
Refreshed Speaker Faculty Including:
Ramila Peiris
Head of Global Data Management, Machine Learning & Artificial Intelligence, Platform, Manufacturing Science & Technology
Sanofi
What Made Us Different?
"Was great to have the chance to be with leading PAT practitioners and exchange and discuss about the current trends, opportunities and challenges in the pharma business. I enjoyed many high-quality talks."
Head of Advanced Analytical Technologies, Roche
"The great opportunity to meet with PAT experts and share the advances and usage of PAT and chemometrics models within my company. Delighted to have learned more on other platforms such as Biotech and Cell and Gene Therapies."
Global Statistical & PAT Lead, Novartis
Previously Attending Companies Include:
World-Class Speaker Faculty Includes:
Darren Whitaker
Associate Director, Automation & Control in Process Chemistry Development
Takeda Pharmaceutical
Sankaran Anantharaman
Head of Process Analytical Technology & Innovation Labs -Principal Research Scientist II, Analytical Sciences, Product Developme
Abbvie
Our Partners:
